Clinical treatment of depressive patients with Anshendingzhi decoction  by Yang, Jianyu et al.
TOPIC
JTCM |www. journaltcm. com December 15, 2014 |Volume 34 | Issue 6 |
Online Submissions: http://www.journaltcm.com J Tradit Chin Med 2014 December 15; 34(6): 652-656
info@journaltcm.com ISSN 0255-2922
© 2014 JTCM. All rights reserved.
CLINICAL STUDY
Clinical treatment of depressive patients with Anshendingzhi decoc-
tion
Jianyu Yang, Lijuan Jiang, Yang Li, Qingwen Zhu, Dong Liu,Wugeng Xue, Bolong Cao, Yingke Liu, XingWang
aa
Jianyu Yang, Yang Li, National Prominent Chinese Medi-
cine Guangrong Sun Inheritance Studio, Beijing University
of Chinese Medicine, Beijing 100029, China
Jianyu Yang, Yang Li, Dong Liu, Yingke Liu, The Promi-
nent Chinese Medicine Doctors' Studio, Beijing Hepingli
Hospital, Beijing 100013, China
Lijuan Jiang, Department of Science and Education, Yun-
nan Provincial Hospital of Traditional Chinese Medicine, Kun-
ming 650021, China
Qingwen Zhu, Preclinical School of Beijing University of Chi-
nese Medicine, Beijing 100029, China
Wugeng Xue, School of Basic Medical, Beijing Fangzhuang
Communuty Health Service Center, Beijing 100078, China
Bolong Cao, Department of Endocrinology, Eastern Area of
Dongzhimen Hospital, Beijing University of Chinese Medi-
cine, Beijing 101121, China
Xing Wang, Department of Traditional Chinese Medicine,
Beijing Tongrentang Hospital of Traditional Chinese Medi-
cine, Beijing 100051, China
Supported by The Project of National Prominent Chinese
Medicine Inheritance Studio, State Chinese Medicine Admin-
istration Bureau (No. 2011.42); Research Project of Beijing
Administration of Traditional Chinese Medicine (No.
JJ2011-91; No. JJ2011-53); The Project of the Prominent Chi-
nese Medicine Doctors' Studio in Beijing Hepingli Hospital,
State Development and Reform Test Area of Traditional Chi-
nese Medicine (Dongcheng District, Beijing); National
Non-material Cultural Heritage — The Project of Chinese
Medicine Master Studio in Beijing Tongrentang
Correspondence to: Prof. Lijuan Jiang, Department of Sci-
ence and Education, Yunnan Provincial Hospital of Tradition-
al Chinese Medicine, Kunming 650021, China. Jiangli-
juan825@163.com
Telephone: +86-13668781266
Accepted: April 15, 2014
Abstract
OBJECTIVE: To determine the effects of Anshend-
ingzhi decoction (ASDZD) on depression, to com-
pare ASDZD with Danzhixiaoyao pill (DZXYP), and
to provide evidence for the clinical treatment of de-
pression with Traditional Chinese Medicine.
METHODS: Seventy-eight patients with depression
were enrolled from 2011 to 2013 in this dou-
ble-blinded study. Patients were randomly divided
into two groups: ASDZD (treatment group, n=39)
and DZXYP (control group, n=39). Hamilton Depres-
sive Scale and TCM Syndrome Differentiation Scale
were used to assess depression and efficacy before
treatment and 2, 4, and 6 weeks after treatment.
The Treatment Emergent Symptoms Scale (TESS)
was used to evaluate adverse reactions, observe,
and record treatment outcomes.
RESULTS: ASDZD was significantly more effective
than DZXYP. There were significant differences be-
tween the two groups in terms of recovered pa-
tients, overall response rate, and TESS score (all P<
0.05).
CONCLUSION: ASDZD is an effective treatment for
depression. ASDZD could improve clinical symp-
toms and warrants further clinical research and ap-
plication.
© 2014 JTCM. All rights reserved.
Key words: Depression; Anshendizhi decoction;
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INTRODUCTION
Depression (or depressive disorder) is a common affec-
tive disorder characterized by an obvious and persistent
reduction in mood. Emotions range from sadness to
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grief, self-abasement, and depression, and the disorder
can result in suicide.1 In Traditional Chinese Medicine
(TCM), depression is considered to be "melancholia",
and was described almost 2000 years ago in Huang Di
Nei Jing 2 as Wu Yu Zhi Ze (rules of treatments with
depression). Most current Western medicine treat-
ments for depression include side effects that are often
coupled with withdrawal symptoms, and can cause un-
favorable effects on the recovery of patients.3,4 The com-
mon treatments for depression in TCM are based on
syndrome differentiation. For example, Duan5 divided
depression into two aspects of asthenia and sthenia,
and then treated patients based on syndrome differenti-
ation. Peng et al 6 divided depression into six types of
syndromes for treatment.
TCM reportedly has favorable treatment efficacy on de-
pression, and is often accompanied by few or no side
effects.7-10 Based on the Xiaoyao powder documented
in Tai Ping Hui Min He Ji Ju Fang,11 Danzhixiaoyao
pill (DZXYP) is composed of: Mudanpi (Cortex Mout-
an Radicis) and Zhizi (Fructus Gardeniae). DZXYP has
the advantages of ease of use and wide clinical adop-
tion. Li et al 12 performed a randomized double-blind
controlled study with 32 depressive patients treated
with DZXYP, and 31 depressive patients treated with
maprotiline. The results showed an approximately
equivalent curative effect of DZXYP and maprotiline.
Both treatments could significantly reduce the Hamil-
ton Rating Scale for Depression (HAMD), Zung's
Self-Rating Depression Scale (SDS), and Zung
Self-Rating Anxiety Scale (SAS) scores in patients with
depression. Liu et al 13 also found that DZXYP was
equally effective in patients with both hypertension
and depression. We used Anshendingzhi decoction
(ASDZD) to treat depression, and compared it with
Danzhixiaoyao pill (DZXYP), a commonly used TCM
treatment for depression.
MATERIALS ANDMETHODS
Subjects
Seventy-eight patients with depression were enrolled
between January 2010 and June 2013. This study was
approved by the ethical committee of Beijing Hepingli
Hospital and informed consent was obtained from all
participants. Using the digital table method, patients
were divided randomly into a treatment and control
group. In the treatment group, there were 16 males
and 23 females aged 20-49 years [mean, (29±8) years],
with a mean course of disease (15±13) months. In the
control group, there were 18 males and 18 females
aged 20-49 years [mean, (30 ± 8) years], with a mean
disease course of (16±15) months. There were no sig-
nificant differences in general demographics between
the two groups (P>0.05).
Diagnosis criteria
The diagnosis criteria used for depression were from
the Chinese Categories and Diagnosis Criteria of Men-
tal Disorders.14
Inclusion criteria
Inclusion criteria were: HAMD score>20; aged be-
tween 18 and 65 years; no treatment with anti-depres-
sive or anti-anxiety drugs 1 week before admission; no
alcohol or drug abuse history; adherent to treatment
regimens; and signed informed consent.
Exclusion criteria
Patients were excluded if they: did not meet the diag-
nosis criteria; had heart, brain, kidney, liver, or other
serious organ diseases; were pregnant or lactating; or
had multiple drug allergies.
Treatment
The treatment group was given ASDZD orally, once
per day after two infusions with warm water. Each
course of treatment lasted 2 weeks. The ingredients of
ASDZD were: Dangshen (Radix Codonopsis) 10 g;
Huangqi (Radix Astragali Mongolici) 10 g, Danshen
(Radix Salviae Miltiorrhizae) 7 g, Fuxiaomai (Fructus
Tritici Levis) 15 g, Dazao (Frutus Jujubae) 10 g, Gan-
cao (Radix Glycyrrhizae) 5 g, Fushen (Poria Cum Radix
Pini) 10 g, fried Suanzaoren (Semen Ziziphi Spinosae)
10 g, Yujin (Radix Curcumae Wenyujin) 10 g, processed
Yuanzhi (Radix Polygalae) 10 g, Shichangpu (Rhizoma
Acori Tatarinowii) 10 g, and Dengxincao (Medulla seu
Herba Junci) 3 g. Drugs above were added or subtract-
ed from the decoction according to different clinical
symptoms (avoid fried granules, Guandong Yifang
Pharmaceutical Co., Ltd., Guangdong, China).
The control group was given DZXYP 6 g each bag, 6-9 g
each time, twice a day. The total courses of the two
groups were 6 weeks. The formula for DZXYP in-
cludes: Mudanpi (Cortex Moutan Radicis), Zhizi (Fruc-
tus Gardeniae, browned by heating), Chaihu (Radix Bu-
pleuri Chinensis, processed with wine), Baishao (Radix
Paeoniae Alba, wine fried), Danggui (Radix Angelicae
Sinensis), Baizhu (Rhizoma Atractylodis Macrocephalae,
soil fried), Fuling (Poria), Bohe (Herba Menthae haploc-
alycis), and honey fried Gancao (Radix Glycyrrhizae).
Ginger juice was also contained within the drug (Chi-
nese Drug Approval Number is z22025769, Jilin prov-
ince Tiantai Pharmaceutical Co., Ltd., Jilin, China).
Observation index
HAMD score and Chinese Medicine Syndrome Differ-
entiation Scale (CMSDS) scores were recorded before
treatment and 2, 4, and 6 weeks after treatment to as-
sess efficacy. The Asberg Treatment Emergent Symp-
tom Scale (TESS)15 was used to evaluate adverse reac-
tions.
Efficacy evaluation criteria
Efficacy was ranked as: cured, markedly effective, im-
proved, and ineffective. Cured was considered when
patients exhibited no psychiatric symptoms, and had a
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HAMD score<8. Markedly effective was considered
when patients' psychiatric symptoms almost disap-
peared and when they had a HAMD score reduce over
50% from before treatment. Improved was considered
when patients had improved psychiatric symptoms,
and had a HAMD score reduce over 30% from before
treatment. Ineffective was considered when the psychi-
atric symptoms and HAMD scores did not improve.
Total number of effective cases=cured+markedly effective + im-
proved.
Statistical analysis
Data were analyzed by SPSS 19.0 (SPSS, Chicago, IL,
USA). The data were expressed as mean±standard devi-
ation (SD) and analyzed by t-test. The enumeration da-
ta were analyzed by χ2 test. P<0.05 was considered sta-
tistically significant.
RESULTS
Comparison of effects between groups
Eighty patients recruited in this study were randomly
divided into a treatment and control group with 40 pa-
tients in each. After the trial, all patients who complet-
ed the trial in two groups (treatment group 39 cases, 1
case lost to follow-up, control group 39 cases, 1 case
discontinued intervention) conducted a follow-up.
The flow diagram of the trial is shown in Figure 1.
After treatment, the overall response rate of ASDZD
was 94.9%, which was significantly better than that of
DZXYP (74.3%) (χ2=4.82, P<0.05) (Table 1).
HAMD and CMSDS scores
Compared with before treatment, the HAMD and
CMSDS scores all significantly decreased after treat-
ment (all P<0.05), and the scores in the treatment
group were significantly lower than those in the con-
trol group after treatment (all P<0.05) (Tables 2, 3).
Adverse reactions
There were significant differences in adverse reactions
between the two groups (all P<0.05). In the treatment
group, there was one case of dizziness, two of nausea,
two of sweating, and one of weakness. In the control
group, there were three cases of headache, two of
thirst, three of nausea, three of sweating, one of fibrilla-
tion, and one of weakness. All adverse reactions were
reduced by adjustment of drug dosage (Table 4).
DISCUSSION
In TCM, depression is considered "Melancholia," and
is caused by stagnation of Qi and emotional distur-
bance. For example, Zhu16 considered that if Qi and
blood are in harmony and flow smoothly, then they do
not cause problems. However, in the depressed state,
Qi and blood are affected. Qian17 considered that Qi is
Group
Treatment
Control
Cured (n)
22
15
Markedly effective (n)
12
8
Improved (n)
3
6
Ineffective (n)
2
10
Total effective rate (%)
94.9
74.3
Notes: the treatment group was treated with ASDZD (one dose a day) and the control group was treated with DZXYP (one dose a day).
Each course of treatment consisted of 2 weeks. ASDZD: Anshendingzhi decoction; DZXYP: Danzhixiaoyao pill.
Table 1 Therapeutic effect between groups
Figure 1 Flow diagram of the trial
Assessed for eligibility
(n=80)
Enrolled and
randomized (n=80)
Treatment group
(n=40)
Control group
(n=40)
Completed 6 weeks
treatment (n=39)
Lost to follow-up (n=1)
Completed 6 weeks
treatment (n=39)
Discontinued
intervention (n=1)
Analysed (n=39) Analysed (n=39)
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the base of personality, and if Qi is in harmony, then
all organs will function properly. However, improper
diet or emotional states can cause Qi movement distur-
bances, which can cause internal organ stasis and subse-
quent disease. Therefore, depression treatment should
begin with soothing the liver and regulating Qi.
ASDZD is a popular formula prescribed for depression
in China. The major functions include soothing the liv-
er, regulating Qi, removing stasis, invigorating the
spleen, and replenishing the heart. Among the ingredi-
ents of ASDZD18, Dangshen (Radix Codonopsis) can
supplement the center and boost Qi, strengthen the
spleen, and tonify the lung. Huangqi (Radix Astragali
Mongolici) can tonify Qi, nourish blood, and invigo-
rate splendid yang. Danshen (Radix Salviae Miltiorrhi-
zae) can remove stasis and activate blood circulation,
regulate Qi, and nourish blood. Fushen (Poria Cocos)
can calm the nerves and treat palpitations. Fried Suan-
zaoren (Semen Ziziphi Spinosae) can act as a sedative,
analgesic, and hypnotic on the heart, spleen, liver, and
gallbladder meridians, and can regulate Qi and nourish
blood. Yujin (Curcuma Wenyujin) can clear heart-fire
and resolve depression, activate Qi, and resolve stagna-
tion. Dengxincao (Medulla Junci) can clear away the
heart-fire and relieve restlessness. Chinese dates (Fruc-
tus Jujubae) can supplement the center and boost Qi,
nourish blood, and calm the nerves. Gancao (Radix
Glycyrrhizae Uralensis) can tonify the spleen and boost
Qi. Dazao (Fructus Jujubae), Gancao (Radix Glycyrrhi-
zae Uralensi), and Fuxiaomai (Fructus Tritici) com-
bined with other drugs can mitigate drug properties,
moderate herbal properties, and alleviat the adverse
drug properties.
Syndrome differentiation has long been used to treat
depression in TCM. The common therapeutic meth-
ods include soothing liver-Qi stagnation, regulating Qi
and dispelling stagnation, and invigorating the spleen.1,
5,19,20 To soothe the liver and regulate Qi, we added
more herbs to activate blood circulation, dispel stagna-
tion, strengthen the spleen, and nourish the heart.
Therefore, this ASDZD formula can not only regulate
Qi activity, but also activate Qi, nourish the heart, and
calm the nerves, which fundamentally resolves the pa-
tient's Qi and blood stagnation. We found that the
cure rate of the treatment group was significantly bet-
ter than that of the control group, which only soothed
the liver and dispelled the stagnation. The scores of de-
pression scales and clinical TCM symptoms were also
better in the treatment group than those in the control
group.
Tranquilizing mind therapy (therapy with Chinese
herbs of tranquillizer in mind restless syndrome) using
ASDZD is another effective TCM method for treating
psychiatric disorders. The therapy can be used to treat
pediatric hyperkinesis, insomnia, attention deficit hy-
peractivity disorder (ADHD), and cardiac neurosis.21-24
Liu et al 25 and Yin et al 26 studied the effects of AS-
DZD on the expression of the dopamine transporter in
ADHD rat striatum, and the effects of ASDZD on the
content of COMT in rats with ADHD. They found
that ASDZD was able to moderate ADHD. These re-
sults also indicate that tranquilizing mind therapy
Notes: the treatment group was treated with ASDZD (one dose a day) and the control group was treated with DZXYP (one dose a day).
ASDZD: Anshendingzhi decoction; DZXYP: Danzhixiaoyao pill; HAMD: Hamilton Depressive Scale.
Group
Treatment
Control
Before treatment
35.9±2.5
34.9±4.6
After treatment
2 Weeks
25.9±1.8
28.6±1.0
4 Weeks
17.1±2.2
22.7±1.9
6 Weeks
9.6±1.1
10.3±1.2
Table 2 HAMD score before treatment and 2, 4, and 6 weeks after treatment (score, xˉ ±s)
Group
Treatment
Control
Before treatment
29.3±2.5
28.9±3.3
After treatment
2 Weeks
22.9±1.6
25.6±1.3
4 Weeks
13.1±1.2
17.7±1.6
6 Weeks
6.6±0.4
11.2±0.6
Table 3 CMSDS score before treatment and 2, 4, and 6 weeks after treatment (score, xˉ ±s)
Notes: the treatment group was treated with ASDZD (one dose a day) and the control group was treated with DZXYP (one dose a day).
ASDZD: Anshendingzhi decoction; DZXYP: Danzhixiaoyao pill; CMSDS: Chinese Medicine Syndrome Differentiation Scale.
Group
Treatment
Control
After treatment
2 Weeks
1.5±0.4
2.0±0.3
4 Weeks
1.7±0.5
2.3±0.5
6 Weeks
1.8±0.3
2.5±0.6
Notes: the treatment group was treated with ASDZD (one dose a day) and the control group was treated with DZXYP (one dose a day).
ASDZD: Anshendingzhi decoction; DZXYP: Danzhixiaoyao pill; TESS: Asberg Treatment Emergent Symptom Scale.
Table 4 TESS scores between groups (score, xˉ ±s)
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could stabilize patient mood, enhance patient atten-
tion, and possibly improve clinical symptoms of some
psychiatric disorders.
Our results show that ASDZD can improve depression
symptoms and adjust patient emotions. There were sig-
nificantly fewer adverse events in the treatment group
than in the control group, which indicates that AS-
DZD is a safe treatment method. However, the study
sample size is small, which may affect our conclusions.
In addition, depression is caused by many factors such
as psychology, society, and biology. Factors not related
to the treatment, such as the hospital environment,
may also affect the treatment results. A larger sample
size and combination with other therapies such as psy-
chotherapy may achieve better, more reliable results.
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